Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-30

Clinical Trial Update: Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing retreatment with ipilimumab versus chemotherapy in advanced melanoma was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chemotherapy (chemotherapy)
  • ipilimumab (ipilimumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2015-11-30